Public Company News

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, opht...

2025-06-01 09:39 5320

Zeekr Group Announces May 2025 Delivery Update

HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forMay 2025. In May, Zeekr Group delivered a total of 46,538 vehicles...

2025-06-01 09:30 3019

9F Inc. Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F

BEIJING, May 30, 2025 /PRNewswire/ -- 9F Inc. ("9F" or the "Company") (Nasdaq: JFU), a digital technology service provider aiming to empower institutional partners with advanced financial technologies, today announced that it received a notification letter datedMay 23, 2025 (the "Notification Let...

2025-05-31 04:30 4865

Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)

SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtaine...

2025-05-30 22:00 2358

mF International Limited Announces Results of Annual General Meeting

HONG KONG, May 30, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), aHong Kong-based experienced financial trading solution provider, today announced the results of its annual general meeting of shareholders held inHong Kong on May 30, 2025. At t...

2025-05-30 19:00 3617

Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results

XIAMEN, China, May 30, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedMarch 31, 2025. First Quarter 2025 Financial Highlights: * Total revenue...

2025-05-30 18:00 3999

So-Young Announces Plan to Implement ADS Ratio Change

BEIJING, May 30, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that the Company plans to change the ratio of the Americ...

2025-05-30 17:00 3420

GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal

YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an SCIE-in...

2025-05-30 15:02 2151

Concord Healthcare Announces Official Release of the Proton Therapy Large Model

BEIJING, May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the st...

2025-05-30 04:30 2008

Namibox, Tencent Cloud, and Shenzhen Press Group Publishing House Forge Tripartite Strategic Partnership to Build a Full-chain AI Education Ecosystem

The collaborative business venture is projected to generate over $5 million in revenue for Jinxin Technology by 2025. SHANGHAI, May 29, 2025 /PRNewswire/ -- Jinxin Technology Holding Company (Nasdaq: NAMI), a leading provider of AI-driven digital content and interactive communication technologie...

2025-05-29 21:30 2612

First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the...

2025-05-29 21:04 2017

Lufax Announces Extraordinary General Meeting on June 25, 2025

SHANGHAI, May 29, 2025 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced  that it will hold an extraordinary general meeting of the Company's shareholders (the "EGM") at10...

2025-05-29 21:00 3790

Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence

BOSTON, May 29, 2025 /PRNewswire/ -- On May 20, Medicilon Preclinical Research ( Shanghai) LLC ("Medicilon") announces that it has successfully passed an on-site inspection by the FDA. The company receives an official Establishment Inspection Report (EIR) reaffirming its position as a trusted lead...

2025-05-29 20:30 1691

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral s...

2025-05-29 20:00 2343

Yum China Announces US$510 Million Share Repurchase Agreements for Second Half of 2025 as Part of Broader Capital Return Plan

SHANGHAI, May 29, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that it has entered into share repurchase agreements in the U.S. andHong Kong for an aggregate repurchase amount of approximatelyUS$510 million for the second half ...

2025-05-29 19:14 3802

Canadian Solar Releases 2024 Corporate Sustainability Report

KITCHENER, ON, May 29, 2025 /PRNewswire/ -- Canadian Solar Inc.  (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced the release of its 2024 Sustainability Report. This report highlights the Company's sustainability strategy and performance, includin...

2025-05-29 19:00 2082

OneConnect Announces Annual General Meeting Results

SHENZHEN, China, May 29, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd. ("OneConnect" or the "Company") (NYSE: OCFT and HKEX: 6638), a leading technology-as-a-service provider for the financial services industry in China, today announced the results of its annual general meeting of...

2025-05-29 18:00 3536

Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA

SHENZHEN, China, May 28, 2025 /PRNewswire/ -- On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its independently developed innovative product, GB18. Moreover, GB18 has previo...

2025-05-29 11:47 1521

E-Home Household Service Holdings Limited Announces Share Consolidation

FUZHOU, China, May 27, 2025 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that at an extraordinary general meeting of the Company held onMay 1, 2025 (the "Meeting"), its sha...

2025-05-29 00:21 5213

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities

Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certifi...

2025-05-28 21:00 2523
1 ... 81828384858687 ... 778

Week's Top Stories